JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SABS - Sab Biotherapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SABS Stock
Financials
Financials SABS Stock
Loading...
Loading...
Home
Stocks
Sab Biotherapeutics, Inc. (SABS)
Stock Overview
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
500K
1M
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Company Profile
No description available
Industry
Biotechnology
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
MIAMI BEACH, FL
SABS Stock Price & Analysis - Sab Biotherapeutics | Ledgeburg